So excited to hear @ycommodore.bsky.social discuss βHypertension: Local & Global Interventionsβ at the PCNA Annual Symposium
11.04.2025 15:30 β π 3 π 1 π¬ 0 π 0@ycommodore.bsky.social
Associate Professor,Cardiovascular Nurse Epidemiologist, President GDNANursing.#cardiohealth #immigranthealth #healthequity π¬ππΊπΈ
So excited to hear @ycommodore.bsky.social discuss βHypertension: Local & Global Interventionsβ at the PCNA Annual Symposium
11.04.2025 15:30 β π 3 π 1 π¬ 0 π 0The Cost of Cutting NIH Research: Voices from the Frontlines tradeoffs.org/2025/03/13/c.... Thank you @tradeoffs.org for the opportunity to reflect with Laura LΓ³pez.
19.03.2025 18:37 β π 2 π 0 π¬ 0 π 0Sweetβ¦ first set of pods dropped!!
I loved hosting the @ahascience.bsky.social podcast series: The Link between #CKD and #CVD #CKMSyndrome
Check out the link below for the pods and toolkit
professional.heart.org/en/education...
Though AHA may want to think twice about using my voice π€·ββοΈπ
Iβm grateful for all the wonderful memories created at #AHA24. Until we meet again at #AHA25 in #NOLA! @rantocran.bsky.social @bunmiogungbe.bsky.social @modeldoc.bsky.social
20.11.2024 03:12 β π 5 π 3 π¬ 0 π 0Likewise ! π
20.11.2024 03:02 β π 1 π 0 π¬ 0 π 0We now have @ycommodore.bsky.social discussing her work in LINKED-BP, an @ahascience.bsky.social health-Equity research network project
#AHA24 #AHAMeeting
Starting off strong with presentations from Drs Susmita Parashar, Yvonne Commodore-Mensah and Khadijah Breathett #AHA24 @ahascience.bsky.social
15.11.2024 20:49 β π 4 π 3 π¬ 0 π 0Dr. Keith Churchwell at the podium delivering the keynote at the opening session
Starting us off is Dr. Keith B. Churchwell, the president of the AHA #AHA24 @ahascience.bsky.social
16.11.2024 14:09 β π 4 π 5 π¬ 2 π 1Weβre building on 100 years of hope this year at #AH24. The Centennial Experience captures 100 years of #cardiology history, make time for it this weekend at Scientific Sessions. Thank you for joining us and inspiring us into our second century.
π₯: @dramitkhera.bsky.social
BPROAD presented at #AHA24 showed in those w/ type 2 diabetes & elevated systolic blood pressure (SBP), intensive SBP lowering (<120 mmHg) reduced major adverse CV events (MACE) by 21% compared to standard treatment (<140 mmHg).
Watch this for one attendeeβs take on the data.
Tirzepatide is another option for managing obesity and CVD and improving quality of life in patients with HFpEF & obesity.
Watch this video for perspective on the data presented at #AHA24. #cardiology